DK2305689T3 - Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser - Google Patents
Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelserInfo
- Publication number
- DK2305689T3 DK2305689T3 DK10181699.9T DK10181699T DK2305689T3 DK 2305689 T3 DK2305689 T3 DK 2305689T3 DK 10181699 T DK10181699 T DK 10181699T DK 2305689 T3 DK2305689 T3 DK 2305689T3
- Authority
- DK
- Denmark
- Prior art keywords
- ecteinascidines
- synthesis
- naturally existing
- related relations
- relations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D515/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0202544.3A GB0202544D0 (en) | 2002-02-04 | 2002-02-04 | The synthesis of naturally occuring ecteinascidins and related compounds |
| EP03737360A EP1472261A2 (en) | 2002-02-04 | 2003-02-04 | The synthesis of naturally occuring ecteinascidins and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2305689T3 true DK2305689T3 (da) | 2014-07-14 |
Family
ID=9930352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10181699.9T DK2305689T3 (da) | 2002-02-04 | 2003-02-04 | Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7767659B2 (da) |
| EP (2) | EP1472261A2 (da) |
| JP (2) | JP2005523275A (da) |
| CN (1) | CN1646539A (da) |
| AU (1) | AU2003244453B2 (da) |
| CA (2) | CA2473175C (da) |
| CY (1) | CY1115249T1 (da) |
| DK (1) | DK2305689T3 (da) |
| ES (1) | ES2466025T3 (da) |
| GB (1) | GB0202544D0 (da) |
| MX (1) | MXPA04007527A (da) |
| NZ (1) | NZ534034A (da) |
| PT (1) | PT2305689E (da) |
| RU (1) | RU2306316C9 (da) |
| SI (1) | SI2305689T1 (da) |
| WO (1) | WO2003066638A2 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040059112A1 (en) * | 1994-02-18 | 2004-03-25 | Rinehart Kenneth L. | Ecteinascidins |
| GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
| GB0202544D0 (en) | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
| US20080242670A2 (en) * | 2004-09-29 | 2008-10-02 | Pharma Mar S.A., Sociedad Unipersonal | Anti-Inflammatory Agents |
| EP2576569B1 (en) | 2010-05-25 | 2015-01-14 | Pharma Mar S.A. | Synthetic process for the manufacture of ecteinascidin compounds and intermediates |
| CN104974056B (zh) * | 2015-07-20 | 2017-01-11 | 上海皓元生物医药科技有限公司 | 一种用于制备曲贝替定的高纯度中间体的手性拆分方法 |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
| CN107739387B (zh) * | 2017-10-16 | 2020-01-03 | 上海皓元生物医药科技有限公司 | 一种制备曲贝替定的关键中间体化合物的方法 |
| CN109912629B (zh) | 2017-12-13 | 2021-12-24 | 浙江中科创越药业有限公司 | 天然产物Trabectedin的制备 |
| CN112679513B (zh) * | 2019-10-18 | 2023-08-25 | 南通诺泰生物医药技术有限公司 | 一种制备曲贝替定的关键中间体的方法 |
| CN112679512B (zh) * | 2019-10-18 | 2023-08-25 | 南通诺泰生物医药技术有限公司 | 曲贝替定中间体及其制备方法 |
| TW202203980A (zh) | 2020-04-21 | 2022-02-01 | 西班牙商瑪製藥股份有限公司 | 藥物抗體共軛物 |
| WO2022186221A1 (ja) * | 2021-03-03 | 2022-09-09 | 国立大学法人東京大学 | マクロ環含有新規テトラヒドロイソキノリンアルカロイド化合物 |
| CN115677728A (zh) * | 2022-11-02 | 2023-02-03 | 成都科岭源医药技术有限公司 | 一种海鞘素类化合物中间体的制备方法 |
| WO2024186263A1 (en) * | 2023-03-07 | 2024-09-12 | Axcynsis Therapeutics Pte. Ltd. | Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59225189A (ja) | 1983-06-03 | 1984-12-18 | Shionogi & Co Ltd | キノナミン誘導体およびその製造法 |
| JPS6084288A (ja) | 1983-10-13 | 1985-05-13 | Shionogi & Co Ltd | シアノキノナミンアセテ−ト類およびその製造法 |
| US5256663A (en) | 1986-06-09 | 1993-10-26 | The Board Of Trustees Of The University Of Illinois | Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith |
| ATE69234T1 (de) | 1986-06-09 | 1991-11-15 | Univ Illinois | Ekteinascidine 729, 743, 745, 759a, 759b and 770. |
| US5089273A (en) | 1986-06-09 | 1992-02-18 | Board Of Trustees Of The University Of Illinois | Ecteinascidins 729, 743, 745, 759A, 759B and 770 |
| US5149804A (en) | 1990-11-30 | 1992-09-22 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins 736 and 722 |
| DE3635711A1 (de) | 1986-10-21 | 1988-04-28 | Knoll Ag | 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung |
| FR2697752B1 (fr) | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| US5478932A (en) | 1993-12-02 | 1995-12-26 | The Board Of Trustees Of The University Of Illinois | Ecteinascidins |
| US20040059112A1 (en) | 1994-02-18 | 2004-03-25 | Rinehart Kenneth L. | Ecteinascidins |
| GB9508195D0 (en) | 1995-04-20 | 1995-06-07 | Univ British Columbia | Novel biologically active compounds and compositions,their use and derivation |
| US5721362A (en) | 1996-09-18 | 1998-02-24 | President And Fellows Of Harvard College | Process for producing ecteinascidin compounds |
| US5985876A (en) | 1997-04-15 | 1999-11-16 | Univ Illinois | Nucleophile substituted ecteinascidins and N-oxide ecteinascidins |
| DE69936845T2 (de) | 1998-04-06 | 2008-05-08 | The Board Of Trustees Of The University Of Illinois, Urbana | Halbsynthetische ectein-ascidine |
| WO1999052138A1 (en) | 1998-04-08 | 1999-10-14 | Aeroflex Utmc Microelectronic Systems Inc. | A bipolar transistor having low extrinsic base resistance |
| DE69927014T2 (de) | 1998-05-05 | 2006-06-14 | Pharma Mar Sa | Kultivierung von sessilen meerestieren |
| WO1999058125A1 (en) | 1998-05-11 | 1999-11-18 | Pharma Mar, S.A. | Metabolites of ecteinascidin 743 |
| US6124292A (en) | 1998-09-30 | 2000-09-26 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
| MY164077A (en) | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
| AR035842A1 (es) | 1999-05-14 | 2004-07-21 | Pharma Mar Sa | Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo |
| US6686470B2 (en) | 2000-01-19 | 2004-02-03 | The Trustees Of Columbia University In The City Of New York | Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| US6815544B2 (en) | 2000-02-11 | 2004-11-09 | President And Fellows Of Harvard College | Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds |
| US6569859B1 (en) | 2000-02-22 | 2003-05-27 | President And Fellows Of Harvard College | Synthetic analogs of ecteinascidin-743 |
| SK288017B6 (sk) | 2000-04-12 | 2012-11-05 | Pharma Mar, S. A. | Ecteinascidin having a fused five ring system with a 1,4 bridge, pharmaceutical composition containing it and use thereof |
| MXPA02011319A (es) | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
| US7420051B2 (en) | 2000-05-15 | 2008-09-02 | Pharma Mar, S.A. | Synthetic process for the manufacture of an ecteinaschidin compound |
| AU2001281232A1 (en) | 2000-08-11 | 2002-02-25 | City Of Hope | The anti-neoplastic agent ET-743 inhibits trans activation by SXR |
| JP4391083B2 (ja) | 2000-11-06 | 2009-12-24 | ファルマ・マール・ソシエダード・アノニマ | 効果的な抗腫瘍治療 |
| EP1360337A1 (en) | 2001-02-09 | 2003-11-12 | The Regents Of The University Of California | Ecteinascidin family compounds: compositions and methods |
| GB0117402D0 (en) * | 2001-07-17 | 2001-09-05 | Pharma Mar Sa | New antitumoral derivatives of et-743 |
| GB0119243D0 (en) * | 2001-08-07 | 2001-10-03 | Pharma Mar Sa | Antitumoral analogs of ET-743 |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| WO2003039571A1 (en) | 2001-10-19 | 2003-05-15 | Pharmamar S.A. | Improved use of antitumoral compound in cancer therapy |
| GB0202544D0 (en) | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
| US20040019027A1 (en) | 2002-04-12 | 2004-01-29 | Barry Forman | Method of treating cerebrotendinous xanthomatosis |
| GB0218813D0 (en) | 2002-08-13 | 2002-09-18 | Pharma Mar Sa | DNA sequences from an endosymbiont and their uses |
| GB0312407D0 (en) | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
| GB0324201D0 (en) | 2003-10-15 | 2003-11-19 | Pharma Mar Sau | Improved antitumoral combinations |
| EP1689404B9 (en) | 2003-11-13 | 2009-04-22 | Pharma Mar, S.A.U. | Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer |
| GB0326486D0 (en) | 2003-11-14 | 2003-12-17 | Pharma Mar Sau | Combination treatment |
| CN1897949A (zh) | 2003-11-14 | 2007-01-17 | 马尔药品公司 | 包含使用et－743和紫杉醇来治疗癌症的联合疗法 |
| US20080242670A2 (en) | 2004-09-29 | 2008-10-02 | Pharma Mar S.A., Sociedad Unipersonal | Anti-Inflammatory Agents |
| CN101119750B (zh) | 2004-10-26 | 2013-03-06 | 法马马私人股份有限公司 | 抗癌治疗 |
| BRPI0517238B1 (pt) | 2004-10-29 | 2021-11-09 | Pharma Mar, S.A. | Composições que compreendem ecteinascidina e um dissacarídeo, método para produzir um frasco que contém a referida composição e para preparar uma solução para infusão intravenosa e uso da referida solução |
| WO2009050303A1 (en) | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Prognostic molecular markers for et-743 treatment |
| WO2009140675A2 (en) | 2008-05-16 | 2009-11-19 | Pharma Mar, S.A. | Combination therapy with an antitumor alkaloid |
| RU2519750C2 (ru) | 2008-05-16 | 2014-06-20 | Фарма Мар, С.А. | Способы лечения множественной миеломы |
-
2002
- 2002-02-04 GB GBGB0202544.3A patent/GB0202544D0/en not_active Ceased
-
2003
- 2003-02-04 DK DK10181699.9T patent/DK2305689T3/da active
- 2003-02-04 SI SI200332350T patent/SI2305689T1/sl unknown
- 2003-02-04 PT PT101816999T patent/PT2305689E/pt unknown
- 2003-02-04 CA CA2473175A patent/CA2473175C/en not_active Expired - Fee Related
- 2003-02-04 MX MXPA04007527A patent/MXPA04007527A/es active IP Right Grant
- 2003-02-04 WO PCT/GB2003/000481 patent/WO2003066638A2/en active Application Filing
- 2003-02-04 CA CA2749205A patent/CA2749205C/en not_active Expired - Lifetime
- 2003-02-04 EP EP03737360A patent/EP1472261A2/en not_active Withdrawn
- 2003-02-04 RU RU2004126700/04A patent/RU2306316C9/ru not_active IP Right Cessation
- 2003-02-04 AU AU2003244453A patent/AU2003244453B2/en not_active Ceased
- 2003-02-04 CN CNA038075768A patent/CN1646539A/zh active Pending
- 2003-02-04 JP JP2003566011A patent/JP2005523275A/ja active Pending
- 2003-02-04 EP EP10181699.9A patent/EP2305689B1/en not_active Expired - Lifetime
- 2003-02-04 US US10/503,106 patent/US7767659B2/en not_active Expired - Fee Related
- 2003-02-04 ES ES10181699.9T patent/ES2466025T3/es not_active Expired - Lifetime
- 2003-02-04 NZ NZ534034A patent/NZ534034A/en not_active IP Right Cessation
-
2008
- 2008-11-19 US US12/273,919 patent/US7795260B2/en not_active Expired - Lifetime
-
2010
- 2010-04-12 US US12/758,182 patent/US7947671B2/en not_active Expired - Lifetime
- 2010-05-26 JP JP2010120823A patent/JP5357831B2/ja not_active Expired - Lifetime
-
2014
- 2014-07-04 CY CY20141100504T patent/CY1115249T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2306316C9 (ru) | 2008-03-27 |
| SI2305689T1 (sl) | 2014-07-31 |
| RU2004126700A (ru) | 2005-06-27 |
| CN1646539A (zh) | 2005-07-27 |
| JP2005523275A (ja) | 2005-08-04 |
| AU2003244453B2 (en) | 2009-03-05 |
| JP2010215645A (ja) | 2010-09-30 |
| ES2466025T3 (es) | 2014-06-09 |
| CA2749205C (en) | 2015-01-06 |
| EP1472261A2 (en) | 2004-11-03 |
| EP2305689A1 (en) | 2011-04-06 |
| AU2003244453A1 (en) | 2003-09-02 |
| EP2305689B1 (en) | 2014-04-09 |
| US7947671B2 (en) | 2011-05-24 |
| US20070093658A1 (en) | 2007-04-26 |
| US20090163507A1 (en) | 2009-06-25 |
| JP5357831B2 (ja) | 2013-12-04 |
| WO2003066638A3 (en) | 2003-12-18 |
| GB0202544D0 (en) | 2002-03-20 |
| CY1115249T1 (el) | 2017-01-04 |
| NZ534034A (en) | 2007-02-23 |
| RU2306316C2 (ru) | 2007-09-20 |
| PT2305689E (pt) | 2014-06-03 |
| MXPA04007527A (es) | 2006-04-28 |
| US7767659B2 (en) | 2010-08-03 |
| WO2003066638A2 (en) | 2003-08-14 |
| US20100216987A1 (en) | 2010-08-26 |
| CA2473175C (en) | 2011-11-15 |
| CA2473175A1 (en) | 2003-08-14 |
| CA2749205A1 (en) | 2003-08-14 |
| US7795260B2 (en) | 2010-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7344A (is) | Stýrð efnasmíði síprasídóns og samsetninga af því | |
| DK3059321T3 (da) | Mikroarray-syntese og -samling af polynukleotider af genlængde | |
| DK1716115T3 (da) | Syntese af acyloxyalkylcarbamat-prodrug og mellemprodukter deraf | |
| DK2075000T3 (da) | Kombination af azelastin og ciclesonid | |
| DK3385267T3 (da) | Syntese af boronestere og syreforbindelser | |
| IS8305A (is) | Bindandi smíðar og aðferðir við notkun þeirra | |
| DK1644384T3 (da) | Fremgangsmåde og mellemprodukter til syntese af entecavir | |
| DK1831154T3 (da) | Fremstilling af pregabalin og relaterede forbindelser | |
| IS7467A (is) | Lansóprasólfjölgervingar og aðferðir við að framleiða þá | |
| DK1470732T3 (da) | Fremskaffelse af lokaliseringsinformation | |
| DK2305689T3 (da) | Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser | |
| NO20043907L (no) | Partielle og fullstendige agonister av A1-adenosinreseptorer | |
| IS7260A (is) | Nýmyndun og hreinsun valasýklóvírs | |
| NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| IS7783A (is) | Flóð og fjöru-ker | |
| DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
| DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
| IS8109A (is) | Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A | |
| DK1572950T3 (da) | Enkeltdomæne TDF-relaterede forbindelser og analoger deraf | |
| DK1565563T3 (da) | Enzymatisk syntese af polyolacrylater | |
| DK1372652T3 (da) | Kombination af docetaxel og flavopiridol | |
| ATE394140T1 (de) | Verwendung neuer etonogestrelester | |
| NO20042126L (no) | Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner | |
| DK1363896T3 (da) | Syntese af beta-lapachol og mellemprodukter derfor | |
| FI20021792A0 (fi) | Jousi- ja kielisoitinrakenne |